Total Funding
74
59
Total FundingGrant raised
Growth Score
34 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
139220
Lydex Pharmaceuticals develops small molecule drug therapy for liver ischemia/reperfusion (IR).
- Sherine Chan: Co-Founder
- C. James Chou: Co-Founder
About the Company
Lydex Pharmaceuticals develops small molecule drug therapy for liver ischemia/reperfusion (IR) to prevent additional damage to the liver during surgical procedures and transplants.
Women Founded
